Morepen Labs betting big on diagnostics devices segment: CMD SECTIONS Last Updated: Apr 25, 2021, 04:07 PM IST Share Synopsis The company is also planning an expansion of its pharmaceutical complex at Baddi in Himachal Pradesh and is looking at an investment of over Rs 178 crore for it. Reuters Drug firm Morepen Laboratories is betting big on the diagnostics devices segment going forward while building its presence in the active pharmaceutical ingredient (API) segment, a top company official said. The company is also planning an expansion of its pharmaceutical complex at Baddi in Himachal Pradesh and is looking at an investment of over Rs 178 crore for it, he added.